Since UCP1 and p38 phosphorylation are key components of the p38 MAPK pathway and were found to be elevated in the WAT of mice with pancreatic cancer in this study, we further tested whether p38 MAPK inhibitors may block the browning of white adipocytes and slow CAC. Here, MAPK14 is linked to familial pancreatic carcinoma.